This study aims to investigate the genetic causes of PAH, and how genetic variation affects outcome and response to treatment.
Researchers are keen to recruit both patients and first degree relatives of patients who have idiopathic or heritable pulmonary arterial hypertension (PAH).
In the below video, Professor Nick Morrell of the University of Cambridge, and study manager Carmen Treacy, talk to PHA UK Iain Armstrong about current research into links between genetics and PAH, and how people can get involved in the study.
Accessibility Tool
Text
Font size
100%
Visual
Translation
Translations are made automatically by Google, not by PHA UK, and may contain mistakes, especially with medical terms. Don't rely on them for decisions about your health or treatment. If anything is unclear, check the English version or contact us.
Google shows an error?
Google sometimes blocks translation requests with an "unusual traffic" message. Try again in a few minutes, or turn off iCloud Private Relay or your VPN for this site.
Navigation
A highlighted band that follows the pointer. Use the up and down arrow keys to move it.